We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Debra M. Emerson
Debra M. Emerson
Products
PRODUCTS
GenTrac, Inc.
Debra M. Emerson
,
Peter Kesler
, and
Ze Peng
Price:
$117.00
View
Wyeth BioPharma, Division of Wyeth Pharmaceuticals, Inc.
Debra M. Emerson
Price:
$117.00
View
CSL Behring LLC
Debra M. Emerson
and
Susan M. Jackson
Price:
$117.00
View
Barr Laboratories, Inc.
Debra M. Emerson
Price:
$117.00
View
Novo Nordisk A/S
Debra M. Emerson
and
Simone E. Pitts
Price:
$117.00
View
GlaxoSmithKline Biologicals
Debra M. Emerson
,
Dino A. Feigelstock
, and
Omotunde O. Osunsanmi
Price:
$117.00
View
Citra Labs, LLC
Stacey S. Degarmo
,
Debra M. Emerson
, and
Megan A. Haggerty
Price:
$117.00
View
Genzyme Corp.
Stacey S. Degarmo
and
Debra M. Emerson
Price:
$117.00
View
Genzyme Corp.
Debra M. Emerson
Price:
$117.00
View
Upcoming Events
07
Apr
FDA CDS Software Regulation: The Latest Guidance on Clinical Decision Support Software
08
Apr
PART 4: Clinical Trials in the Era of COVID-19 - The Changes You Need to Make Now
10
Apr
EU-MDR: Are You Ready? Part II: Tips for Assessing Your Readiness Prior to Notified Body Review
16
Apr
Medical Device Change Management
21
Apr
FDA’s Regulation of Digital Health Wearables & Sensors
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Gilead Begins Remdesivir Trials in the UK
FDA Clears First Coronavirus Antibody Test for Use During Pandemic
ElectroCore Seeks EUA for Vagus Nerve Stimulation Therapy
Emergent BioSolutions Partners with HHS for Plasma-Derived COVID-19 Treatment
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
